Corporate/M&A

Baker McKenzie's New York Corporate / M&A practice advises public and private companies, with a focus in the pharmaceuticals, manufacturing, specialty chemicals/building products, financials, energy, media and telecommunications industries. Our clients range from small-cap emerging growth private companies and venture capital funds to top global private equity funds, public companies and their investment bankers. These deals range from small, private domestic acquisitions to multi-billion dollar, complex cross-border transactions. We are an acknowledged leader, particularly on cross-border transactions, and our practice is helping our clients rethink their growth strategies and extract greater value from their transactions. This full-service capability is rare for transactions spanning multiple jurisdictions and sets us apart from other global law firms.

For nearly 70 years, we have guided clients on the buy-side and sell-side of complex multi-jurisdictional transactions. Over the past decade, we completed more cross-border transactions than any other firm in the world. Not only do we offer a unique combination of local expertise with an experienced team of global deal lawyers, but we are fully integrated and truly know one another—the key to a seamless multi-jurisdictional transaction. We invested in and refined our processes to drive efficiencies and provide the highest standards and deal practices, enabling us to execute deals with more precision than our competitors.